c-Myc Inhibits Ras-Mediated Differentiation of Pheochromocytoma Cells by Blocking c-Jun Up-Regulation

Although mutant Ras proteins were originally described as transforming oncoproteins, they induce growth arrest, senescence, and/or differentiation in many cell types. c-Myc is an oncogenic transcription factor that cooperates with Ras in cellular transformation and oncogenesis. However, the Myc-Ras relationship in cellular differentiation is largely unknown. Here, we have analyzed the effects of c-Myc on PC12-derived cells (UR61 cell line), harboring an inducible N-Ras oncogene. In these cells, Ras activation induces neuronal-like differentiation by a process involving c-Jun activation. We found that c-Myc inhibited Ras-mediated differentiation by a mechanism that involves the blockade of c-Jun induction in response to Ras signal. Accordingly, ectopically expressed c-Jun could bypass c-Myc impediment of Ras-induced differentiation and activator protein 1 activation. Interestingly, it did not rescue the proliferative arrest elicited by Ras and did not enhance the differentiation-associated apoptosis. The blockade of Ras-mediated induction of c-Jun takes place at the level of c-Jun proximal promoter. Mutational analysis revealed that c-Myc regions involved in DNA binding and transactivation are required to block differentiation and c-Jun induction. c-Myc does not seem to require Miz-1 to inhibit differentiation and block c-Jun induction. Furthermore, Max is not required for c-Myc activity, as UR61 cells lack a functional Max gene. c-Myc–inhibitory effect on the Ras/c-Jun connection is not restricted to UR61 cells as it can occur in other cell types as K562 or HEK293. In conclusion, we describe a novel interplay between c-Myc and c-Jun that controls the ability of Ras to trigger the differentiation program of pheochromocytoma cells. (Mol Cancer Res 2008;6(2):325–39)

[1]  N. Saxena,et al.  RAS: Target for Cancer Therapy , 2008, Cancer investigation.

[2]  M. Eriksson,et al.  Mitogen activated protein kinase‐dependent activation of c‐Jun and c‐Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells , 2007, Journal of cellular physiology.

[3]  Zhiping Weng,et al.  Global mapping of c-Myc binding sites and target gene networks in human B cells , 2006, Proceedings of the National Academy of Sciences.

[4]  Kathryn A. O’Donnell,et al.  The c-Myc target gene network. , 2006, Seminars in cancer biology.

[5]  Dirk Eick,et al.  Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules. , 2006, Chemistry & biology.

[6]  S. McMahon,et al.  Targeting of Miz-1 Is Essential for Myc-mediated Apoptosis* , 2006, Journal of Biological Chemistry.

[7]  T. Herdegen,et al.  MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling , 2005, Molecular and Cellular Neuroscience.

[8]  C. Arvanitis,et al.  Conditionally MYC: insights from novel transgenic models. , 2005, Cancer letters.

[9]  M. Eilers,et al.  Transcriptional regulation and transformation by Myc proteins , 2005, Nature Reviews Molecular Cell Biology.

[10]  Javier León,et al.  Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes , 2005, Oncogene.

[11]  D. Matallanas,et al.  Myc Antagonizes Ras-mediated Growth Arrest in Leukemia Cells through the Inhibition of the Ras-ERK-p21Cip1 Pathway* , 2005, Journal of Biological Chemistry.

[12]  R. Sears.  The Life Cycle of C-Myc: From Synthesis to Degradation , 2004, Cell cycle.

[13]  S. McMahon,et al.  Analysis of genomic targets reveals complex functions of MYC , 2004, Nature Reviews Cancer.

[14]  S. Narumiya,et al.  The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. , 2004, Molecular cell.

[15]  C. Frassoni,et al.  SNAP-25 Modulation of Calcium Dynamics Underlies Differences in GABAergic and Glutamatergic Responsiveness to Depolarization , 2004, Neuron.

[16]  J. León,et al.  Kinetics of myc‐max‐mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress‐mediated induction of c‐myc , 2004, Molecular carcinogenesis.

[17]  John L Cleveland,et al.  Myc pathways provoking cell suicide and cancer , 2003, Oncogene.

[18]  D. Beach,et al.  Myc confers androgen-independent prostate cancer cell growth. , 2003, The Journal of clinical investigation.

[19]  C. Cordon-Cardo,et al.  Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. , 2003, Cancer research.

[20]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[21]  M. Eilers,et al.  Transcriptional repression by Myc. , 2003, Trends in cell biology.

[22]  M. Eilers,et al.  Negative regulation of the mammalian UV response by Myc through association with Miz-1. , 2002, Molecular cell.

[23]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[24]  M. Eilers,et al.  Contributions of Myc to tumorigenesis. , 2002, Biochimica et biophysica acta.

[25]  P. Fernandez,et al.  Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. , 2001, Genes & development.

[26]  W. Ansorge,et al.  Complex Functions of AP-1 Transcription Factors in Differentiation and Survival of PC12 Cells , 2001, Molecular and Cellular Biology.

[27]  N. Hay,et al.  Myc drives apoptosis in PC12 cells in the absence of Max , 2001, Oncogene.

[28]  M. Yaniv,et al.  The mammalian Jun proteins: redundancy and specificity , 2001, Oncogene.

[29]  C. Crosio,et al.  Borna Disease Virus Persistent Infection Activates Mitogen-activated Protein Kinase and Blocks Neuronal Differentiation of PC12 Cells* , 2001, The Journal of Biological Chemistry.

[30]  R. Cardiff,et al.  c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations , 2001, Nature Medicine.

[31]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[32]  L. Boxer,et al.  Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. , 2000, European journal of cell biology.

[33]  J. Lipski,et al.  c-Jun promotes neurite outgrowth and survival in PC12 cells. , 2000, Brain research. Molecular brain research.

[34]  P. Crespo,et al.  Ras proteins in the control of the cell cycle and cell differentiation , 2000, Cellular and Molecular Life Sciences CMLS.

[35]  P. Crespo,et al.  H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism , 2000, Oncogene.

[36]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[37]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[38]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[39]  W. Ansorge,et al.  Differential regulation of c‐Jun by ERK and JNK during PC12 cell differentiation , 1998, The EMBO journal.

[40]  A. Muñoz,et al.  Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. , 1997, Genes & development.

[41]  J. Bos.  Ras-like GTPases. , 1997, Biochimica et biophysica acta.

[42]  Joseph R. Nevins,et al.  Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F , 1997, Nature.

[43]  C. Dang,et al.  Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells , 1997, Oncogene.

[44]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[45]  D. Shalloway,et al.  Cell cycle-dependent activation of Ras , 1996, Current Biology.

[46]  B. Amati,et al.  Growth arrest by the cyclin‐dependent kinase inhibitor p27Kip1 is abrogated by c‐Myc. , 1996, The EMBO journal.

[47]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[48]  E. Ziff,et al.  The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max , 1995, Molecular and cellular biology.

[49]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[50]  J. León,et al.  Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[51]  R. Flavell,et al.  AP‐1 transcriptional activity requires both T‐cell receptor‐mediated and co‐stimulatory signals in primary T lymphocytes. , 1994, The EMBO journal.

[52]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[53]  B. Seliger,et al.  Thyroid hormone receptor/c-erbA: control of commitment and differentiation in the neuronal/chromaffin progenitor line PC12 , 1993, The Journal of cell biology.

[54]  S. Hattori,et al.  Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells. , 1992, Oncogene.

[55]  P. Brown,et al.  The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells , 1991, Molecular and cellular biology.

[56]  M. Benito,et al.  Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. , 1991, Science.

[57]  M. Karin,et al.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain , 1991, Nature.

[58]  K. Yokoyama,et al.  Nucleotide sequence of rat c-jun protooncogene. , 1990, Nucleic acids research.

[59]  C. Der,et al.  ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun , 1989, Molecular and cellular biology.

[60]  W. Rutter,et al.  Nerve growth factor induces the proto-oncogene c-jun in PC12 cells. , 1989, The Journal of biological chemistry.

[61]  R. Jaenisch,et al.  The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Peter Angel,et al.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 , 1988, Cell.

[63]  D. Burstein,et al.  Dissociation of c-fos from ODC expression and neuronal differentiation in a PC12 subline stably transfected with an inducible N-ras oncogene. , 1988, Biochemical and Biophysical Research Communications - BBRC.

[64]  P. Herrlich,et al.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region , 1987, Molecular and cellular biology.

[65]  P. Leder,et al.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.

[66]  H. Varmus,et al.  Definition of regions in human c-myc that are involved in transformation and nuclear localization , 1987, Molecular and cellular biology.

[67]  D. Burstein,et al.  Activated N‐ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells , 1986, Journal of cellular physiology.

[68]  A. Ogura,et al.  Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line , 1985, Nature.

[69]  D. Bar-Sagi,et al.  Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation , 1985, Cell.

[70]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[71]  L. Greene,et al.  Regulation of acetylcholinesterase activity by nerve growth factor. Role of transcription and dissociation from effects on proliferation and neurite outgrowth. , 1981, The Journal of biological chemistry.

[72]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[73]  L. Penn,et al.  The myc oncogene: MarvelouslY Complex. , 2002, Advances in cancer research.

[74]  R. Eisenman,et al.  The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.

[75]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.